Advertisement

Topics

Chinese drug authority accepts Eisai's NDA for Perampanel to treat partial onset seizures

07:20 EDT 13 Oct 2018 | PharmaBiz

Eisai Co, Ltd has announced that the National Medical Products Administration of China has accepted for review a New Drug Application for Eisai's antiepileptic drug (AED) perampanel (generic name, product

Original Article: Chinese drug authority accepts Eisai's NDA for Perampanel to treat partial onset seizures

NEXT ARTICLE

More From BioPortfolio on "Chinese drug authority accepts Eisai's NDA for Perampanel to treat partial onset seizures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...